107th Annual General Meeting of Shareholders

About the 107th Annual General Meeting

Santen Pharmaceutical Co., Ltd. held its 107th Annual General Meeting of Shareholders for the fiscal year 2018 on June 25, 2019. The Meeting started at 10:00 a.m. and ended at 11:38 a.m. The number of shareholders attended was 209.

Matters reported
  1. Business Report, Consolidated Financial Statements and Non-consolidated Financial Statements for the 107th Business Term (April 1, 2018 to March 31, 2019)
  2. Independent Auditors Report and Corporate Auditors Report on the consolidated Financial Statements for the 107th Business Term (April 1, 2018 to March 31, 2019)
Questions We received questions regarding the following subjects from 9 shareholders and responded in kind.
  • Regarding standard of trade receivables
  • Regarding global cash management.
  • Regarding current share price
  • Regarding trend of OTC sales.
  • Regarding business expansion other than ophthalmic drugs.
  • Regarding abolition of hand gifts to attended shareholders.
  • Regarding questionnaire to shareholders.
  • Regarding attendance card.
  • Regarding disaster-prevention for earthquake and etc. in domestic manufacturing plant.
  • Regarding bottle design of Soft Santear ®
  • Regarding sales promotion enhancement through internet
  • Regarding employment's willingness to work
  • Regarding plan for headquarter relocation to Tokyo.
  • Regarding reason for the long-term loans payable increase.
Matters resolved Three proposals were all resolved.
Please refer to the Resolution Notice (PDF: 230KB)PDF for detailed resolutions.